We also tested FGFR2 specificity using the CCLP-1 ICC cell line, which lacks an FGFR2 fusion and is driven by FGFR1 and FGF20 overexpression (3). The gene discussed is FGF20; the disease is intrahepatic cholangiocarcinoma.